Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZW) Shares Outstanding (Diluted Average) (2020 - 2025)

Core Scientific (CORZW) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $318.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 24.33% to $318.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $318.1 million through Dec 2025, up 24.33% year-over-year, with the annual reading at $318.1 million for FY2025, 24.33% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $318.1 million in Q4 2025 for Core Scientific, roughly flat from $318.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $379.9 million in Q4 2023 to a low of $158.9 million in Q2 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $295.2 million across 5 years, with a median of $317.3 million in 2025.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 104.52% in 2022 and later plummeted 44.9% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $233.3 million in 2021, then skyrocketed by 46.01% to $340.6 million in 2022, then grew by 11.51% to $379.9 million in 2023, then crashed by 32.65% to $255.8 million in 2024, then rose by 24.33% to $318.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CORZW at $318.1 million in Q4 2025, $318.6 million in Q3 2025, and $316.6 million in Q2 2025.